Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Merck Issues Statement On WHO Study Showing First Evidence That Elimination Of River Blindness Is Feasible In Africa
Merck & Co., Inc. issued the following statement in response to study results published today by the World Health Organization offering the first evidence that elimination of the tropical disease river blindness (onchocerciasis) in Africa is feasible with treatment with ivermectin (registered trademark Mectizan®). As the discoverer and manufacturer of Mectizan, Merck decided in 1987 to donate the drug to all who need it for as long as necessary until river blindness is eliminated as a public health problem. The Merck Mectizan Donation Program is one of the longest-running disease-specific drug donation and public/private partnership programs in history.
generic viagra online
Cost-Effective Measures Could Stop Child Pneumonia Deaths
Implementing measures to improve nutrition, indoor air pollution, immunization coverage and the management of pneumonia cases could be cost-effective and significantly reduce child mortality from pneumonia, according to a study led by the Johns Hopkins Bloomberg School of Public Health. Researchers found that these strategies combined could reduce total child mortality by 17 percent and could reduce pneumonia deaths by more than 90 percent. Pneumonia is a leading cause of death of infants in many developing countries, resulting in 2.2 million deaths each year. The study is published in the June 2009 issue of the Bulletin of the World Health Organization.
News of the day
FDA Authorizes Emergency Use Of Another Test For 2009 H1N1 Influenza Virus
The U.S. Food and Drug Administration announced it has issued an Emergency Use Authorization (EUA) for a another diagnostic test for the 2009 H1N1 influenza virus, whose spread has caused the virus to be characterized as a pandemic by the World Health Organization.
Cardiovascular

Patient Radiation Exposure During Interventional Procedures Is A Concern For Some Developing Countries

Interventional radiology procedures are on the rise in developing countries and there is a significant need for optimization of these procedures to ensure patient safety. Many facilities in these countries lack the concept of patient dose estimation and dose management, putting patients at a higher risk of developing complications due to overexposure from radiation during interventional procedures, according to a study performed by the International Atomic Energy Agency in Vienna, Austria. The study included data from 55 hospitals in 20 countries - mostly in Eastern Europe, five in Africa and six in Asia. "We found that a substantial number of coronary angioplasty procedures performed in the developing countries in this study are above the currently known dose reference level," said Madan M. Rehani, PhD, coordinator of the study. "We also found that kerma area product (KAP), a method to determine dose estimations, was available in almost half of the facilities, but none had experience in its use," said Dr. Rehani. "There is a significant lack of awareness about patient dose estimations and dose management among interventional radiologists and cardiologists in developing countries. Our goal is to introduce these concepts to them and achieve effective implementation," he said. "Most training centers need to establish a culture of dose assessment and dose management - including programs for residents with radiation protection as an essential component - to improve patient safety. Dose monitoring devices for angiography equipment should also be considered," said Dr. Rehani. This study appears in the August issue of the American Journal of Roentgenology. Abstract Heather Curry American Roentgen Ray Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009